| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000021224 |
| Receipt No. | R000024479 |
| Official scientific title of the study | Exploratory research into biomarkes for neurodegenerative diseases in peripheral blood and cerebrospinal fluid |
| Date of disclosure of the study information | 2016/02/29 |
| Last modified on | 2019/03/08 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Exploratory research into biomarkes for neurodegenerative diseases in peripheral blood and cerebrospinal fluid | |
| Title of the study (Brief title) | Exploratory research into biomarkes for neurodegenerative diseases | |
| Region |
|
|
| Condition | ||
| Condition | Neurodegenerative diseases
(especially Parkinson's disease and related disorder, amyotrophic lateral sclerosis) |
|
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To establish biomarkers available for clinic settings |
| Basic objectives2 | Others |
| Basic objectives -Others | This is not a research of drug administration |
| Trial characteristics_1 | |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | |
| Assessment | |
| Primary outcomes | To identify proteins that is useful for disease biomarker |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | target diseases | |||
| Key exclusion criteria | nothing particular | |||
| Target sample size | 180 | |||
| Research contact person | |
| Name of lead principal investigator | Ryosuke Takahashi |
| Organization | Kyoto University Graduate School of Medicine |
| Division name | Department of Neurology |
| Address | 54 Kawaharacho, Shogoin, Sakyo-ku Kyoto, Japan |
| TEL | 075-751-3111 |
| ryosuket@kuhp.kyoto-u.ac.jp | |
| Public contact | |
| Name of contact person | Shinya Okuda |
| Organization | Kyoto University Graduate School of Medicine |
| Division name | Department of Neurology |
| Address | 54 Kawaharacho, Shogoin, Sakyo-ku Kyoto, Japan |
| TEL | 075-751-3767 |
| Homepage URL | |
| okudas@kuhp.kyoto-u.ac.jp | |
| Sponsor | |
| Institute | Kyoto University Graduate School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japan Agency for Medical Research and Development(AMED) |
| Organization | |
| Division | |
| Category of Funding Organization | |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | The targets will be elected from the patients who consult our department and are diagnosed as Parkinson's disease, related disorder and amyotrophic laterral sclerosis since April 2016 to March 2021. Their cerebrospinal fluid and peripheral blood will be analysed.
(The patients is not continuously observed.) |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000024479 |